L. Fehrenbacher
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology
- Cancer Research top 10%
- Genetics top 10%
- Co-authors
- Alan SandlerRóbert HermannDiane PragerRoy S. HerbstDavid A. RamiesMark G. KrisVincent A. MillerPam Klein
- Topics
- Cancer Treatment and Pharmacology (11 papers)Colorectal Cancer Treatments and Studies (9 papers)Lung Cancer Research Studies (7 papers)
- Partner nations
- United StatesSouth KoreaBelgium
In The Last Decade
L. Fehrenbacher
33 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 62
- Oncology 1.4k
- Pulmonary and Respiratory Medicine 1.4k
- Molecular Biology 355
- Cancer Research 229
- Genetics 86
Countries citing papers authored by L. Fehrenbacher
This map shows the geographic impact of L. Fehrenbacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Fehrenbacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Fehrenbacher more than expected).
Fields of papers citing papers by L. Fehrenbacher
This network shows the impact of papers produced by L. Fehrenbacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Fehrenbacher. The network helps show where L. Fehrenbacher may publish in the future.
Co-authorship network of co-authors of L. Fehrenbacher
This figure shows the co-authorship network connecting the top 25 collaborators of L. Fehrenbacher. A scholar is included among the top collaborators of L. Fehrenbacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Fehrenbacher. L. Fehrenbacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | 132 | |
| 3 | 16 | |
| 4 | 5 | |
| 5 | 2 | |
| 6 | 5 | |
| 7 | 2 | |
| 8 | Efficacy, safety and predictive biomarker results from a randomized phase II study comparing atezolizumab vs docetaxel in patients with advanced NSCLC (POPLAR) | 1 |
| 9 | 1 | |
| 10 | 28 | |
| 11 | 4 | |
| 12 | 3 | |
| 13 | 2 | |
| 14 | 34 | |
| 15 | 25 | |
| 16 | 14 | |
| 17 | 2 | |
| 18 | 40 | |
| 19 | 16 | |
| 20 | 23 |
About L. Fehrenbacher
L. Fehrenbacher is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 33 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Colorectal Cancer Treatments and Studies (9 papers) and Lung Cancer Research Studies (7 papers). The work is most often cited by research in Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.4k citations) and Cancer Research (229 citations). L. Fehrenbacher has collaborated with scholars based in United States, South Korea and Belgium. Frequent co-authors include Alan Sandler, Róbert Hermann, Diane Prager, Roy S. Herbst, David A. Ramies, Mark G. Kris, Vincent A. Miller, Pam Klein, David H. Johnson and Bruce E. Johnson. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.